{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Merkel ED"],"funding":["Magyar Tudományos Akadémia"],"pubmed_abstract":["<h4>Aims</h4>Primary prevention of sudden cardiac death (SCD) in non-ischemic heart failure (HF) patients remains a topic of debate at cardiac resynchronization therapy (CRT) implantation requiring individual risk assessment. Using the Goldenberg SCD risk score, we aimed to predict, which non-ischemic HF patients will benefit from the addition of an implantable cardioverter defibrillator (ICD) to CRT at long-term.<h4>Methods</h4>Between 2000 and 2018 non-ischemic HF patients undergoing CRT implantation were collected into our retrospective registry. The Goldenberg risk score (GRS) was calculated by the presence of atrial fibrillation, New York Heat Association (NYHA) class > 2, age > 70 years, blood urea nitrogen > 26 mg/dl and QRS > 120 ms. The primary endpoint was all-cause mortality, he"],"journal":["Frontiers in cardiovascular medicine"],"pagination":["1062094"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9871919"],"repository":["biostudies-literature"],"pubmed_title":["Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure-Role of the Goldenberg risk score."],"pmcid":["PMC9871919"],"pubmed_authors":["Kosztin A","Geller L","Schwertner WR","Veres B","Molnar L","Zima E","Behon A","Merkely B","Osztheimer I","Kuthi L","Papp R","Merkel ED"],"additional_accession":[]},"is_claimable":false,"name":"Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure-Role of the Goldenberg risk score.","description":"<h4>Aims</h4>Primary prevention of sudden cardiac death (SCD) in non-ischemic heart failure (HF) patients remains a topic of debate at cardiac resynchronization therapy (CRT) implantation requiring individual risk assessment. Using the Goldenberg SCD risk score, we aimed to predict, which non-ischemic HF patients will benefit from the addition of an implantable cardioverter defibrillator (ICD) to CRT at long-term.<h4>Methods</h4>Between 2000 and 2018 non-ischemic HF patients undergoing CRT implantation were collected into our retrospective registry. The Goldenberg risk score (GRS) was calculated by the presence of atrial fibrillation, New York Heat Association (NYHA) class > 2, age > 70 years, blood urea nitrogen > 26 mg/dl and QRS > 120 ms. The primary endpoint was all-cause mortality, he","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-08-31T03:09:25.489Z","creation":"2025-04-05T21:40:06.391Z"},"accession":"S-EPMC9871919","cross_references":{"pubmed":["36704467"],"doi":["10.3389/fcvm.2022.1062094"]}}